AR109456A2 - USE OF ET743 FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF A HUMAN PATIENT AFFECTED BY CANCER THROUGH COMBINATION THERAPY - Google Patents
USE OF ET743 FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF A HUMAN PATIENT AFFECTED BY CANCER THROUGH COMBINATION THERAPYInfo
- Publication number
- AR109456A2 AR109456A2 ARP170101288A ARP170101288A AR109456A2 AR 109456 A2 AR109456 A2 AR 109456A2 AR P170101288 A ARP170101288 A AR P170101288A AR P170101288 A ARP170101288 A AR P170101288A AR 109456 A2 AR109456 A2 AR 109456A2
- Authority
- AR
- Argentina
- Prior art keywords
- cancer
- preparation
- treatment
- combination therapy
- human patient
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 title abstract 2
- 238000002648 combination therapy Methods 0.000 title abstract 2
- 229940126601 medicinal product Drugs 0.000 title 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 abstract 1
- 229960003957 dexamethasone Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Uso de ET743 para la preparación de un medicamento para el tratamiento de un paciente humano afectado por cáncer mediante terapia de combinación, involucrando la administración de ET743 y dexametasona.Use of ET743 for the preparation of a medicament for the treatment of a human patient affected by cancer by combination therapy, involving the administration of ET743 and dexamethasone.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9911183.3A GB9911183D0 (en) | 1999-05-13 | 1999-05-13 | Treatment of cancers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR109456A2 true AR109456A2 (en) | 2018-12-12 |
Family
ID=10853439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP170101288A AR109456A2 (en) | 1999-05-13 | 2017-05-15 | USE OF ET743 FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF A HUMAN PATIENT AFFECTED BY CANCER THROUGH COMBINATION THERAPY |
Country Status (4)
| Country | Link |
|---|---|
| CN (1) | CN101181272A (en) |
| AR (1) | AR109456A2 (en) |
| ES (1) | ES2363064T3 (en) |
| GB (1) | GB9911183D0 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112574234B (en) * | 2019-09-27 | 2022-05-24 | 江苏恒瑞医药股份有限公司 | Preparation method of ecteinascidin derivative |
-
1999
- 1999-05-13 GB GBGB9911183.3A patent/GB9911183D0/en not_active Ceased
-
2000
- 2000-05-15 ES ES06014005T patent/ES2363064T3/en not_active Expired - Lifetime
- 2000-05-15 CN CNA2007101863681A patent/CN101181272A/en active Pending
-
2017
- 2017-05-15 AR ARP170101288A patent/AR109456A2/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2363064T3 (en) | 2011-07-19 |
| GB9911183D0 (en) | 1999-07-14 |
| CN101181272A (en) | 2008-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE515265T1 (en) | VITAMIN D AND ITS ANALOGUES FOR THE TREATMENT OF TUMORS AND OTHER HYPERPROLIFERATIVE DISEASES | |
| CY1112361T1 (en) | PACKAGES FOR ANTI-CANCER THERAPEUTIC CONTAINERS 743 | |
| PT1173178E (en) | COMPOSITION UNDERSTANDING APOMORPHINE AND SILDENAFIL AND USES THEMSELVES FOR THE TREATMENT OF ERECTILE DISFUNCTION | |
| EP1194173A4 (en) | ADMINISTRATION OF MEDICINE GUIDED BY X-RAY | |
| DE60115029D1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING CANNABIDIOL DERIVATIVES | |
| IL195723A (en) | Use of p53 inhibitors for the preparation of medicament | |
| TR200001891T2 (en) | ASPB28- Human insulin and its use. | |
| MXPA05012810A (en) | Memantine oral dosage forms. | |
| TW200501945A (en) | Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases | |
| NO994165L (en) | Use of descarboethoxyloratadine for the manufacture of a medicament for the treatment of urinary incontinence, travel sickness and dizziness | |
| BRPI0406858A (en) | Controlled release of highly soluble agents | |
| AR023687A1 (en) | A COMPOSITION FOR THE TREATMENT OF EXTERNAL RETINA DISORDERS AND THE USE OF A GLUTAMATE ANTAGONIST FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF EXTERNAL RETINA DISORDERS | |
| ES2191449T3 (en) | DERIVATIVES OF CICLOPENTABENZOFURANO AND ITS USE. | |
| HRP20090345T1 (en) | Pegylated liposomal doxorubicin in combination with ecteinescidin 743 | |
| PL368686A1 (en) | Novel aminobenzoephenones | |
| CA2385755A1 (en) | Prevention of colorectal cancer | |
| AR109456A2 (en) | USE OF ET743 FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF A HUMAN PATIENT AFFECTED BY CANCER THROUGH COMBINATION THERAPY | |
| AR027394A1 (en) | USE OF MIRTAZAPINE FOR THE TREATMENT OF SOIL DISORDERS | |
| AR034142A1 (en) | A PHARMACEUTICAL COMPOSITION, METHOD FOR MANUFACTURING A MEDICINAL BASED ON SUCH COMPOSITION AND USE OF THE COMPOSITION | |
| AR048318A1 (en) | ORAL MATRIX FORMULATIONS THAT INCLUDE LICARBAZEPINA | |
| AU3401093A (en) | Therapeutic agent for threatened abortion | |
| IL156144A0 (en) | Novel therapeutic use of a thienylcyclohexylamine derivative | |
| BR0311141A (en) | Synergistically interaction of abacavir and alovudine | |
| UY27508A1 (en) | THERAPEUTIC APPLICATION OF SELECTIVE AGONISTS OF THE BETA RECEPTOR STROGENOR (ERB) TO CAUSE SOMATOTROPIC AND ANTI-CATABOLIC EFFECTS | |
| MD1780G2 (en) | Method of treatment of patients with hepatic cirrhosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |